Latest Insider Transactions at Celularity Inc (CELU)
This section provides a real-time view of insider transactions for Celularity Inc (CELU). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Celularity Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Celularity Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 13
2023
|
Bradley Glover Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,884
-0.81%
|
$0
$0.71 P/Share
|
|
Mar 27
2023
|
Robert J Hariri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,084,854
+17.03%
|
$0
$0.83 P/Share
|
|
Mar 15
2023
|
Kyle Fletcher Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,170
-0.84%
|
$0
$0.63 P/Share
|
|
Feb 17
2023
|
John R Haines Senior Exec Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+46.21%
|
-
|
|
Feb 17
2023
|
Kyle Fletcher Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+46.47%
|
-
|
|
Feb 17
2023
|
Stephen Brigido Pres., Functional Regeneration |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+46.21%
|
-
|
|
Feb 17
2023
|
Bradley Glover Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+45.87%
|
-
|
|
Feb 17
2023
|
David C Beers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+46.21%
|
-
|
|
Feb 17
2023
|
Adrian Kilcoyne Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
Feb 10
2023
|
Peter Diamandis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,071,000
+49.17%
|
$0
$0.28 P/Share
|
|
Nov 30
2022
|
Robert J Hariri Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.12%
|
$10,000
$1.72 P/Share
|
|
Nov 29
2022
|
Robert J Hariri Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+0.49%
|
$40,000
$1.71 P/Share
|
|
Nov 28
2022
|
Robert J Hariri Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+0.5%
|
$40,000
$1.74 P/Share
|
|
Nov 16
2022
|
Kyle Fletcher Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,262
-3.56%
|
$1,262
$1.89 P/Share
|
|
Nov 16
2022
|
Anne Jones Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,734
-7.06%
|
$3,734
$1.89 P/Share
|
|
Aug 26
2022
|
John Sculley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
768,594
+48.85%
|
$0
$0.28 P/Share
|
|
Aug 24
2022
|
Robert J Hariri Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
119,073
+1.47%
|
$238,146
$2.87 P/Share
|
|
Jul 13
2022
|
Peter Diamandis Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
|
Jul 13
2022
|
John Sculley Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
|
Jul 13
2022
|
Kok Thay Lim |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
|
Jul 13
2022
|
Dean C Kehler Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
|
Jul 13
2022
|
Bradley Glover Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,124
+28.57%
|
-
|
|
Jul 13
2022
|
Marc Mazur Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
|
Jul 13
2022
|
Diane L. Parks Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
|
Jul 13
2022
|
Anne Jones Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,483
+29.17%
|
-
|
|
Jul 13
2022
|
Kyle Fletcher Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,297
+6.09%
|
-
|
|
Jul 13
2022
|
Robin L Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+50.0%
|
-
|
|
Jul 13
2022
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,145
+20.98%
|
-
|
|
Apr 13
2022
|
Anne Jones Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,405
+50.0%
|
-
|
|
Apr 13
2022
|
Bradley Glover Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,686
+50.0%
|
-
|
|
Apr 13
2022
|
David C Beers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,011
+50.0%
|
-
|
|
Apr 13
2022
|
Stephen Brigido Pres., Functional Regeneration |
BUY
Grant, award, or other acquisition
|
Direct |
32,809
+50.0%
|
-
|
|
Apr 13
2022
|
Keary Dunn Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,405
+50.0%
|
-
|
|
Apr 13
2022
|
Robert J Hariri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
131,234
+1.64%
|
-
|
|
Apr 13
2022
|
John R Haines Senior Exec Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
65,617
+50.0%
|
-
|
|
Mar 01
2022
|
Starr International CO Inc > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
6,640,694
+30.29%
|
$19,922,082
$3.5 P/Share
|
|
Nov 16
2021
|
Bradley Glover Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,734
-6.46%
|
$3,734
$1.89 P/Share
|
|
Nov 16
2021
|
Bradley Glover Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+30.19%
|
-
|
|
Nov 16
2021
|
Anne Jones Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+32.1%
|
-
|
|
Nov 09
2021
|
Andrew C. Von Eschenbach Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$0
$0.28 P/Share
|
|
Jul 16
2021
|
Kok Thay Lim |
BUY
Grant, award, or other acquisition
|
Indirect |
30,062,778
+30.21%
|
$300,627,780
$10.0 P/Share
|
|
Jul 16
2021
|
Robert J Hariri Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
7,734,689
+50.0%
|
-
|
|
Jul 16
2021
|
Dean C Kehler Director |
SELL
Other acquisition or disposition
|
Indirect |
7,087,500
-98.61%
|
-
|
|
Jul 16
2021
|
Dean C Kehler Director |
BUY
Conversion of derivative security
|
Indirect |
7,187,500
+50.0%
|
-
|
|
Jul 16
2021
|
Gx Sponsor LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
7,087,500
-98.61%
|
-
|
|
Jul 16
2021
|
Gx Sponsor LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
7,187,500
+50.0%
|
-
|
|
Jul 16
2021
|
Jay R Bloom Director |
SELL
Other acquisition or disposition
|
Indirect |
7,087,500
-98.61%
|
-
|
|
Jul 16
2021
|
Jay R Bloom Director |
BUY
Conversion of derivative security
|
Indirect |
7,187,500
+50.0%
|
-
|